Court ruling favors Mylan in Copaxone patent dispute


A US court has dismissed claims that US generic drugmaker Mylan (Nasdaq: MYL) infringed four patents…

CopaxoneGenericsMomenta PharmaceuticalsMylan LaboratoriesNatco PharmaNeurologicalNorth AmericaPatentsSandozTeva Pharmaceutical Industries

Teva prevails in Copaxone law suit with Mylan/Natco and Sandoz/Momenta


Israel-headquartered Teva Pharmaceutical Industries (Nasdaq: TEVA) says that the US District Court for…

CopaxoneGenericsLegalMomenta PharmaceuticalsMylan LaboratoriesNatco PharmaNeurologicalNorth AmericaPatentsPharmaceuticalSandozTeva Pharmaceutical Industries

US Supreme Court agrees to hear generic drug labelling case; Teva files to stop generic Copaxone


The USA’s highest court has agreed to hear appeals by Israel’s Teva Pharmaceutical Industries…

ActavisCopaxoneGenericsLegalMomenta PharmaceuticalsMylan LaboratoriesNeurologicalNorth AmericaNovartisPatentsPharmaceuticalRegulationSandozTeva Pharmaceutical Industries

Back to top